Single Case Experimental Designs Strategies for Studying Behavior Change
, by Barlow, David H.; Nock, Matthew K.; Hersen, Michael- ISBN: 9780205474554 | 0205474551
- Cover: Hardcover
- Copyright: 2/26/2008
Preface | p. xv |
Epigram | p. xvii |
The Single Case in Basic and Applied Research: An Historical Perspective | p. 1 |
Introduction | p. 1 |
Beginnings in Experimental Physiology and Psychology | p. 2 |
Origins of the Group Comparison Approach | p. 4 |
The influence of inferential statistics | p. 6 |
Development of Applied Research: The Case Study Method | p. 8 |
Early reports of percentage of success in treated groups | p. 10 |
The development of the group comparison approach in applied research | p. 11 |
Limitations of Early Group Comparison Approaches | p. 13 |
Ethical objections and practical problems | p. 13 |
Averaging of results | p. 14 |
Generality of findings | p. 14 |
Intersubject variability | p. 15 |
Early Alternative Approaches to Applied Research | p. 15 |
Naturalistic studies | p. 16 |
Process research | p. 18 |
The Scientist-Practitioner Split | p. 19 |
A Return to the Individual | p. 20 |
The role of the case study | p. 22 |
The representative case | p. 22 |
Shapiro's methodology in the clinic | p. 23 |
Quasi-experimental designs | p. 24 |
Chassan and intensive designs | p. 25 |
The Experimental Analysis of Behavior | p. 26 |
General Issues in a Single-Case Approach | p. 31 |
Introduction | p. 31 |
Variability | p. 32 |
Variability in basic research | p. 32 |
Variability in applied research | p. 33 |
Clinical vs. statistical significance | p. 34 |
Highlighting variability in the individual | p. 35 |
Repeated measures | p. 35 |
Rapidly changing designs | p. 36 |
Experimental Analysis of Sources of Variability Through Improvised Designs | p. 37 |
Subject fails to improve | p. 37 |
Subject improves "spontaneously" | p. 38 |
Subject displays cyclical variability | p. 40 |
Searching for "hidden" sources of variability | p. 41 |
Behavior Trends and Intrasubject Averaging | p. 42 |
Relation of Variability to Generality of Findings | p. 45 |
Generality of Findings | p. 46 |
Types of generality | p. 46 |
Problems in generalizing from a single-case | p. 47 |
Some Limitations of Group Designs in Establishing Generality of Findings | p. 48 |
Random sampling and inference in applied research | p. 48 |
Problems in generalizing from the group to the individual | p. 49 |
Improving generality of findings to the individual through homogeneous groups: logical generalization | p. 51 |
Homogeneous Groups Versus Replication of a Single-Case Experiment | p. 52 |
Direct replication and treatment/no-treatment control group design | p. 52 |
Systematic and clinical replication and factorial designs | p. 55 |
Blurring the Distinction Between Design Options | p. 57 |
General Procedures in Single-Case Research | p. 61 |
Introduction | p. 61 |
Repeated Measurement | p. 62 |
Practical implications and limitations | p. 62 |
Choosing a Baseline | p. 65 |
Baseline stability | p. 65 |
Examples of baselines | p. 67 |
Changing One Variable at a Time | p. 73 |
Correct and incorrect applications | p. 73 |
Exceptions to the rule | p. 74 |
Issues in drug evaluation | p. 80 |
Reversal and Withdrawal | p. 81 |
The reversal design | p. 82 |
Reversal and withdrawal designs compared | p. 83 |
Withdrawal of treatment | p. 83 |
Limitations and problems | p. 87 |
Length of Phases | p. 88 |
Individual and relative length | p. 88 |
Carryover effects | p. 91 |
Cyclic variation | p. 93 |
Evaluation of Irreversible Procedures | p. 94 |
Exceptions | p. 95 |
Assessing Response Maintenance | p. 97 |
Behavior Assessment | p. 99 |
Selection of Behavior to Assess | p. 102 |
Social significance | p. 102 |
Clinical significance | p. 104 |
Organizational significance | p. 104 |
Personal significance | p. 104 |
Measurement of Behavior | p. 105 |
Primary measures: behavioral dimensionals of proximal, directly observed behavior | p. 105 |
Temporality dimensions | p. 106 |
Repeatability dimensions | p. 107 |
Products of behavior | p. 110 |
Behavior rating scales | p. 111 |
Self-reports | p. 113 |
Physiological measures | p. 115 |
Settings for Assessment | p. 120 |
Contrived versus naturalistic settings and observations | p. 120 |
A continuum of contrivance | p. 121 |
Defining the behaviors to be observed | p. 124 |
Selecting observers | p. 125 |
Technically enhanced observation | p. 127 |
Training observers | p. 128 |
Reliability and validity | p. 129 |
The Assessment of Function | p. 131 |
Summary and Conclusions | p. 134 |
Basic A-B-A Withdrawal Designs | p. 135 |
Introduction | p. 135 |
Limitations of the case study approach | p. 135 |
A-B Design | p. 136 |
A-B with follow-up | p. 138 |
A-B with multiple target measures and follow-up | p. 140 |
A-B with follow-up and booster treatment | p. 142 |
A-B-A Design | p. 145 |
A-B-A from the adult literature | p. 146 |
A-B-A from child literature | p. 147 |
A-B-A-B Design | p. 149 |
A-B-A-B from child literature | p. 149 |
A-B-A-B when phase change is not under complete experimental control | p. 151 |
A-B-A-B with unexpected improvement in baseline | p. 153 |
A-B-A-B with monitoring of concurrent behaviors | p. 155 |
A-B-A-B with no feedback to experimenter | p. 156 |
B-A-B Design | p. 158 |
B-A-B with group data | p. 159 |
B-A-B from rogerian framework | p. 161 |
A-B-C-B Design | p. 162 |
A-B-C-B from the child literature | p. 163 |
A-B-C-B in a group application and follow-up | p. 164 |
Extensions of the A-B-A Design, Uses in Drug Evaluation and Interaction Design Strategies | p. 167 |
Extensions and Variations of the A-B-A Withdrawal Design | p. 167 |
A-B-A-B-A-B Design | p. 168 |
Comparing Separate Treatment Variables/Components | p. 169 |
A-B-A-C-A-C'-A design | p. 169 |
Parametric Variations of the Same Treatment Variable/Component | p. 172 |
A-B-A-B-B[subscript 1]-B[subscript 2]-B[subscript 3]-B[subscript N] design | p. 172 |
A-B- B[subscript 1]-B[subscript 2]-A-B[subscript 1] design | p. 173 |
Drug Evaluations | p. 175 |
Issues specific to drug evaluations | p. 176 |
Design options | p. 178 |
Strategies for Studying Interaction Effects | p. 185 |
Changing Criterion Designs | p. 198 |
Multiple Baseline Designs | p. 201 |
Introduction | p. 201 |
Multiple Baseline Designs | p. 202 |
Types of multiple baseline designs | p. 204 |
Multiple baseline design across behaviors | p. 205 |
Multiple baseline design across subjects | p. 218 |
Multiple baseline across settings | p. 228 |
Variations of Multiple Baseline Designs | p. 234 |
Nonconcurrent multiple baseline design | p. 234 |
Multiple-probe technique | p. 235 |
Issues in Drug Evaluations | p. 239 |
Alternating Treatments Design | p. 243 |
Introduction | p. 243 |
History and terminology | p. 245 |
Procedural Considerations | p. 246 |
Multiple-treatment interference | p. 247 |
Counterbalancing relevant experimental factors | p. 252 |
Number and sequencing of alternations | p. 253 |
Examples of Alternating Treatments Designs | p. 254 |
Comparing treatment and no treatment conditions | p. 254 |
Comparing multiple treatments | p. 258 |
Advantages of the Alternating Treatments Design | p. 266 |
Visual Analysis of the Alternating Treatments Designs | p. 267 |
Simultaneous Treatment Design | p. 268 |
Statistical Analyses for Single-Case Experimental Designs | p. 271 |
Introduction and Overview | p. 271 |
Single-Subject Experiments and Time-Series Data | p. 273 |
The nature of time-series data | p. 273 |
Mathematical and graphical description of a time series | p. 274 |
The problem of autocorrelation | p. 275 |
Autocorrelation and human behavior | p. 278 |
General comments | p. 279 |
Specific Statistical Tests | p. 279 |
Conventional t and F tests | p. 279 |
Randomization tests | p. 281 |
Interrupted time-series analysis (ITSA) | p. 287 |
Autoregressive Integrated Moving Average (ARIMA) Models | p. 288 |
Model building process | p. 291 |
Intervention (impact) analysis | p. 294 |
ITSA modeling strategies | p. 296 |
Box-Jenkins-Tiao strategy (Box & Tiao, 1965) | p. 296 |
Full series modeling strategy | p. 296 |
Interrupted time-series experiment (ITSE) | p. 297 |
Example | p. 298 |
Intervention analysis | p. 299 |
Other statistical tests | p. 301 |
Revusky's R[subscript n] (test of ranks) | p. 302 |
Split-middle technique | p. 302 |
Double bootstrap method | p. 303 |
Evaluation of statistical tests: which test to choose? | p. 303 |
Summary and Conclusion | p. 304 |
Beyond the Individual: Direct, Systematic, and Clinical Replication Procedures | p. 307 |
Introduction | p. 307 |
Direct Replication | p. 308 |
Definition of direct replication | p. 308 |
two successful replications | p. 309 |
four successful replications with design alterations during replications | p. 312 |
mixed results in a multiple baseline design | p. 316 |
simultaneous replication in a group | p. 319 |
Guidelines for direct replication | p. 321 |
Systematic Replication | p. 322 |
Definition of systematic replication | p. 322 |
Example: differential attention in children | p. 323 |
Comment on replication | p. 333 |
Guidelines for systematic replication | p. 333 |
Clinical Replication | p. 336 |
Definition of clinical replication | p. 337 |
Example: clinical replication with autistic children | p. 337 |
Benchmarking | p. 339 |
Practice Research Networks | p. 340 |
Advantages of Replication of Single-Case Experiments | p. 341 |
Hiawatha Designs an Experiment | p. 343 |
References | p. 347 |
Subject Index | p. 375 |
Name Index | p. 383 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.
Digital License
You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.
More details can be found here.